Inventor

DURANT GRAHAM J

124 patents

⚠️ This page may combine multiple inventors who share the name “DURANT GRAHAM J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SMITH KLINE FRENCH LAB

30 patents

US4154834AMay 15, 1979

Substituted isocytosines having histamine H2 -antagonist activity

SMITH KLINE FRENCH LAB62 citations96

US4216318AAug 5, 1980

Heterocyclic alkyl 4-pyrimidones

SMITH KLINE FRENCH LAB35 citations93

US4145546AMar 20, 1979

4-Pyrimidone compounds

SMITH KLINE FRENCH LAB34 citations93

US4255428AMar 10, 1981

5-(Hydroxypyridylalkyl)-4-pyrimidones

SMITH KLINE FRENCH LAB19 citations82

US4399142AAug 16, 1983

Pharmacologically active compounds

SMITH KLINE FRENCH LAB7 citations74

US4282234AAug 4, 1981

Certain heterocyclic-methylthioalkyl guanidine derivatives

SMITH KLINE FRENCH LAB5 citations74

US4215126AJul 29, 1980

Alkoxy pyridine compounds

SMITH KLINE FRENCH LAB5 citations74

US4173644ANov 6, 1979

Thiourea compounds, compositions and methods and use

SMITH KLINE FRENCH LAB7 citations74

US4156727AMay 29, 1979

Alkoxy pyridine compounds

SMITH KLINE FRENCH LAB11 citations74

US4154838AMay 15, 1979

Alkoxy pyridine

SMITH KLINE FRENCH LAB12 citations74

US4154844AMay 15, 1979

Pharmacologically active guanidine compounds in compositions and methods of use

SMITH KLINE FRENCH LAB6 citations74

US4152453AMay 1, 1979

Pharmacologically active compounds and compositions and methods of use

SMITH KLINE FRENCH LAB8 citations74

US4137237AJan 30, 1979

Pharmacologically active guanidine compounds

SMITH KLINE FRENCH LAB4 citations74

US4333946AJun 8, 1982

Blocking histamine H2 -receptors with imidazolylalkyl guanidine derivatives

SMITH KLINE FRENCH LAB5 citations73

US4247558AJan 27, 1981

Pyridyl alkylguanidines

SMITH KLINE FRENCH LAB3 citations73

US4812573AMar 14, 1989

Pharmaceutically active compounds

SMITH KLINE FRENCH LAB14 citations72

US4294854AOct 13, 1981

Pharmaceutical compositions

SMITH KLINE FRENCH LAB6 citations72

US4285952AAug 25, 1981

Pyridyl, thiazolyl and isothiazolyl alkyl bisamidines

SMITH KLINE FRENCH LAB5 citations72

US4265896AMay 5, 1981

Amidinosulphonic acid derivatives

SMITH KLINE FRENCH LAB5 citations72

US4210658AJul 1, 1980

Amidinosulphonic acid derivatives

SMITH KLINE FRENCH LAB9 citations72

US4277485AJul 7, 1981

Oxazole or isoxazole alkylamino ethylene compounds as inhibitors of H-2 histamine receptors

SMITH KLINE FRENCH LAB7 citations69

US4228291AOct 14, 1980

Pharmacologically active thiadiazole guanidine compounds

SMITH KLINE FRENCH LAB8 citations68

US4694008ASep 15, 1987

Chemical compounds

SMITH KLINE FRENCH LAB5 citations63

US4600720AJul 15, 1986

Pharmacologically active compounds

SMITH KLINE FRENCH LAB2 citations63

US4578388AMar 25, 1986

Unsymmetrical guanidino, thioureido, isothioureido and nitromethyleneamino derivatives

SMITH KLINE FRENCH LAB2 citations63

US4578459AMar 25, 1986

Heterocyclic alkylaminoheterocycles

SMITH KLINE FRENCH LAB6 citations63

US4521418AJun 4, 1985

Guanidinothiazolyl derivatives

SMITH KLINE FRENCH LAB5 citations63

US4467087AAug 21, 1984

1,2,4-Triazines

SMITH KLINE FRENCH LAB3 citations63

US4438127AMar 20, 1984

Pharmacologically active compounds

SMITH KLINE FRENCH LAB3 citations63

US4426526AJan 17, 1984

Alkoxypyridyl alkylamines

SMITH KLINE FRENCH LAB1 citations63

CAMBRIDGE NEUROSCIENCE INC

12 patents

US5298657AMar 29, 1994

Preparation of substituted guanidines

CAMBRIDGE NEUROSCIENCE INC40 citations93

US5489709AFeb 6, 1996

Preparation of substituted guanidines

CAMBRIDGE NEUROSCIENCE INC16 citations79

US6156741ADec 5, 2000

Therapeutic substituted guanidines

CAMBRIDGE NEUROSCIENCE INC10 citations74

US6147063ANov 14, 2000

Therapeutic substituted guanidines

CAMBRIDGE NEUROSCIENCE INC10 citations74

US6013675AJan 11, 2000

Therapeutic substituted guanidines

CAMBRIDGE NEUROSCIENCE INC8 citations74

US5955507ASep 21, 1999

Therapeutic substituted guanidines

CAMBRIDGE NEUROSCIENCE INC6 citations74

US5922772AJul 13, 1999

Therapeutic substituted guanidines

CAMBRIDGE NEUROSCIENCE INC5 citations74

US6787569B1Sep 7, 2004

Therapeutic guanidines

CAMBRIDGE NEUROSCIENCE INC8 citations73

US5847006ADec 8, 1998

Therapeutic guanidines

CAMBRIDGE NEUROSCIENCE INC15 citations73

US6025355AFeb 15, 2000

Pharmaceutically active compounds and methods of use

CAMBRIDGE NEUROSCIENCE INC10 citations72

US6143791ANov 7, 2000

Therapeutic guanidines

CAMBRIDGE NEUROSCIENCE INC12 citations71

US6153604ANov 28, 2000

Therapeutic substituted guanidines

CAMBRIDGE NEUROSCIENCE INC5 citations63

UNIV TOLEDO

3 patents

US5403845AApr 4, 1995

Muscarinic agonists

UNIV TOLEDO94 citations93

US5175166ADec 29, 1992

Muscarinic agonists

UNIV TOLEDO86 citations93

US5486526AJan 23, 1996

Histamine H3 -receptor antagonists and therapeutic uses thereof

UNIV TOLEDO13 citations72

SCION PHARMACEUTICALS INC

1 patent

US7041702B1May 9, 2006

Pharmaceutically active compounds and methods of use

SCION PHARMACEUTICALS INC30 citations91

CENES PHARMACEUTICALS INC

1 patent

US6358993B1Mar 19, 2002

Pharmaceutically active nitrogen ring compounds and methods of use thereof

CENES PHARMACEUTICALS INC15 citations90

CAMBRIDGE NEUROSCIENCES INC

1 patent

US6288123B1Sep 11, 2001

Therapeutic guanidines

CAMBRIDGE NEUROSCIENCES INC26 citations88

WYETH CORP

1 patent

US7351743B1Apr 1, 2008

Therapeutic guanidines

WYETH CORP10 citations82

SK & F LAB CO

1 patent

US4381395AApr 26, 1983

Process for preparing an imidazole derivative

SK & F LAB CO10 citations73

Showing the top 50 of 124 patents by PatentIndex Score.